Smadja, David M. https://orcid.org/0000-0001-7731-9202
Mauge, Laetitia
Rancic, Jeanne
Gaussem, Pascale
Feraud, Olivier
Oudrhiri, Noufissa
Bennaceur-Griscelli, Annelise
Funding for this research was provided by:
Université Paris-Saclay (Université Paris-Saclay)
Inserm (Inserm)
inserm (inserm)
Infrastructure INGESTEM ANR (ANR-11-INBS-0009)
Article History
Accepted: 25 November 2024
First Online: 29 November 2024
Declarations
:
: Human umbilical cord was provided by Saint-Louis Hospital Biological Resources Center - Cord Blood Bank after information and consent of mothers, under French Health Ministry authorization (n°AC-2016-2759). Venous blood from healthy, informed donors was supplied by the French Blood Bank Institute under an agreement with Paris Cité University (CCPSL UNT N 12/EFS/064). Peripheral venous blood (PB) samples (20 ml) were collected in plastic heparin-anticoagulant tubes and processed within 4 h. The ethical approval on human Embryonic Stem Cells (hESC) refers to the nominally authorization granted to Dr. A Bennaceur-Griscelli from Inserm Unit UMR U935/U1310, and delivered by the Biomedicine Agency. The first approval was granted on June 26, 2006, under the references R06-006R and RE06017R/1, allowing the importation of the hESC line H9 and conducting research. The research project received extensions, with a renewal of authorization in 2011 and another in 2016 under the reference RE10-035 R/C. The latest renewal authorized a 5-year period from January 26, 2017, published in the French Official Journal (JORF No. 0143) on June 20, 2017 (text No. 15).
: The mothers for cord blood and patients for adult blood provided their written informed consent to participate in this study.
: The mothers for cord blood and patients for adult blood provided their written informed consent for the publication of the study.
: NA.